Google’s $10B Monopoly Payment: US Government’s Antitrust Showdown
In a landmark antitrust trial in Washington, the U.S.
Tech Titans Apple and Google Face Off in Antitrust Showdown
In the ever-evolving tech landscape, the dynamic between industry giants Apple Inc (NASDAQ: AAPL) and Alphabet Inc (NASDAQ: GOOG) (NASDAQ:
How A Small Indian Firm Firm Was Pulled Into A Legal Battle with Big Pharma Over A Cancer Drug
This story was first published on the Benzinga India portal.
Shuttle Pharma Expands Patent Coverage On HDAC Inhibitor Platform
The Company's HDAC pre-clinical inhibitor platform includes:SP-2-225 is Shuttle Pharma's pre-clinical Class IIb selective HDAC inhibitor that affects histone deacetylase HDAC6. SP-2-225 has effects on the regulation of
Japanese YouTuber Faces Jail Time For Monetizing Gameplay Videos
A 53-year-old Japanese man named Shinobu Yoshida was sentenced to two years in prison and fined ¥1 million (around $6,785) for monetizing gameplay videos on Alphabet Inc's (NASDAQ: GOOGL)(NASDAQ: GOOG
Financial Crime Weekly: Rashawn Russell, From Investment Banker To Crypto Fraudster?
Rashawn Russell, a 27-year-old former investment banker at Deutsche Bank AG (NYSE: DB), and a Gates Millennium Leadership Scholarship recipient, found himself deep in a scandal earlier this year that is likely to see him banned professionally trading —
Burford Capital Says Friday’s U.S. Court Ruling In YPF Case Implies A Judgment Against Argentina Of Approximately $16B; Burford Calls The Ruling A ‘Complete Win Against Argentina’
Court's Ruling suggests a final judgment of approximately $16 billion against Argentina
‘Google Files Motion To Dismiss Gannett’s Ad Tech Lawsuit’ – Axios
https://www.axios.com/2023/09/08/google-gannett-antitrust-lawsuit-motion-dismissGoogle on Friday filed a motion to dismiss a federal antitrust lawsuit from Gannett, America's largest newspaper chain. The complaint
Optimi Health Will Supply Psychedelics To Canada’s SAP, Secures CA$1M Private Financing
Health Canada has approved an amendment to Optimi Health’s (OTCQX: OPTHF) dealer's license, effectively allowing the company to supply MDMA and psilocybin drugs to the country’s Special Access Program (SAP.)